Key Insights

Highlights

Treatment Research

4 treatments under study, led by Biospecimen Collection

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06741072Phase 1Recruiting

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Showing all 1 trials

Research Network

Common Treatments

  • Biospecimen Collection1
  • Qs211
  • Dulbeccos Phosphatebuffered Saline1
  • Peptide Vaccine1

Active Sponsors

  • Ohio State University Comprehensive Cancer Center1

Top Investigators

Related Conditions

  • Posttransplant Lymphoproliferative Disorder1
  • Chronic Kidney Disease Stage 41
  • Chronic Kidney Disease Stage 51
  • Ebvrelated Lymphoproliferative Disorder1

Activity Timeline